R. Cosentini (Milan, Italy), A. Torres (Barcelona, Spain)
Serum and bronchoalveolar lavage fluid acute phase reactants and cytokine levels in unilateral community acquired pneumonia
M. Kolsuz, S. Erginel, O. Alatas, M. Metintas, F. Alatas, I. Ucgun, E. Harmanci (Eskisehir, Turkey)
|  |
Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP)
A. Strassburg, G. Van Zandbergen, H. Kothe, A. Wulf, J. Braun, K. Dalhoff (Luebeck, Germany)
| |
Cytokines in BAL fluid from pneumococcal pneumonia
P. Jimenez, X. Cabezas, M. Meneses, F. Saldias, E. Blackburn (Valdivia, Chile)
| |
Pathogen-dependent MMP-8 and MMP-9 excess in hospital acquired pneumonia (HAP)
C. R. Salb, C. M. Hartog, R. Nagel, J. A. Wermelt, E. Muhl, K. Dalhoff, J. Braun (Luebeck, Germany)
| |
Diagnostic utility of IL-6 in the pleural fluid
E. Cases-Viedma, R. Sirera, M. A. Martinez-Garcia, A. Gonzalez-Molina, J. L. Sanchis-Aldas (Valencia, Spain)
| |
D-Dimer as a marker of fibrinolytic activity in complicated parapneumonic effusions and empyema
E. Laserna, J. L. López-Campos, B. Romero, F. Rodríguez-Panadero, E. Barrot (Sevilla, Spain)
| |
Miliary pneumonia - a complication of bacillus calmette-guerin immunotherapy in treatment of bladder cancer
U. Jachmann-Jahn, M. Jachmann (Muennerstadt, Germany)
| |
Legionnaires' disease: diagnostic and therapeutic features about 31 cases
G. Brunin, P. Ducq, R. Pordes (Boulogne Sur Mer, France)
| |
Etiology of acute lower respiratory tract infection in hospitalized patients with protracted symptomatology
E. Balis, J. Papaparaskevas, D. B. Panagiotakos, I. Iliopoulos, A. Boufas, E. Anastasakou, N. J. Legakis, L. Zerva (Athens, Greece)
| |
Risk factors (RF) for community-acquired pneumonia (CAP) in adults. A population-based case-control study
J. Almirall, J. Roig, I. Hospital, E. Carandell, M. Agusti, P. Ayuso, A. Estela, I. Bolibar, M. Serra-Prat, X. Balanzo (Mataro, Valls, Palma de Mallorca, Tarrega, Valencia, Mao, Barcelona, Spain; Andorra la Vella, Andorra)
| |
Community-acquired pneumonia (CAP) in the elderly : aetiology, role of aspiration and diagnostic procedures
A. A. Wulf, A. A. Strassburg, J. J. Rupp, H. H. Kothe, J. J. Braun, M. M. Maass, K. K. Dalhoff (Lübeck, Germany)
| |
Nosocomial pneumonia (NP) acquired during mechanical ventilation in the largest community hospital in southern Italy
L. Occhiochiuso, F. Diurno, R. Teodori, F. Imperatore, M. Cazzola (Naples, Italy)
| |
Community-acquired pneumonia from an adult emergency room - experience of a portuguese pulmonology center
J. Amado, S. Neves, M. C. Brito, R. Duarte (Vila Nova de Gaia, Portugal)
| |
Value of routine microbial investigation in low-risk patients with community-acquired pneumonia (CAP)
S. Putinati, L. Ballerin, M. Piattella, L. Ritrovato, A. Potena (Italy)
| |
Efficacy and safety of Linezolid in pneumonias
A. A. Desai, S. Sinha, P. P. Rao, R. S. Muralidharan, R. Ganesan (Mumbai, Chennai, India)
| |
Efficacy and safety of Cefdinir in lower respiratory tract infections
A. A. Desai, S. Sinha, J. P. Rishi, S. Jayaram, N. T. Awad ()
| |
Penetration of piperacillin and tazobactam into pneumonic human lung-tissue measured by in-vivo microdialysis
F. Tomaselli, A. Maier, P. Dittrich, H. Pinter, F. M. Smolle-Jüttner (Graz, Austria)
| |
Bronchopulmonary pharmacokinetic (PK) profile of moxifloxacin in older adults undergoing diagnostic bronchoscopy
B. Capitano, H. M. Mattoes, E. T. Shore, A. D. O'Brien, S. S. Braman, C. H. Nightingale, D. P. Nicolau (Hartford, Providence, United States Of America)
| |
Bacterial agents of community-acquired lower respiratory tract infections: observational study on antimicrobial drugs susceptibility
P. Ruggeri, E. Crisafulli, G. Giacobbe, G. Girbino ()
| |
Exposure to sub-lethal levels of penicillin G and high osmotic potential leads to stable antibiotic resistance in Staphylococcus aureus
C. L. Elmer, P. J. Cook, P. Cheung, T. Fawcett (Durham, United Kingdom)
| |